Article Text

Download PDFPDF
Bradyarrhythmias in patients with atrial fibrillation
  1. Mariana Floria1,2,
  2. Daniela Maria Tanase1,2
  1. 1Internal Medicine, Emergency County Hospital Saint Spiridon, Iasi, Romania
  2. 2Grigore T Popa University of Medicine and Pharmacy, Iasi, Romania
  1. Correspondence to Dr Mariana Floria, Emergency County Hospital Saint Spiridon, Iasi 700115, Romania; floria_mariana{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The increasing burden of atrial fibrillation (AF) and significant morbidity/mortality associated with this arrhythmia encourage screening it in clinical practice, as recommended in current guidelines. It means opportunistic screening (in patients over 65 years) or systematic screening (in people above 75 years) by using clinical examination, followed by an ECG, 24-hour ECG monitoring or continuous rhythm monitoring by a screening tool (including mobile or wearable device). In screen-positive cases, a definitive diagnosis of AF should always be obtained before providing an appropriate management.1 Symptomatic or asymptomatic AF is described as either clinical or atrial high-rate episode/subclinical AF; the last one may represent a marker rather than a risk factor for stroke, with these complications probably at lower rates than those of clinical AF. From this point of view, in the current guidelines, bradyarrhythmias in patients with AF were less discussed, being less studied in clinical trials.1

Until now, clinical studies have mainly focused on episodes with AF, symptomatic or asymptomatic, clinical or subclinical. Apart from the episodes of bradyarrhythmias in sinus node disease, those associated with the evolution of AF have been neglected from either incidence, diagnostic, clinical significance, therapeutic or prognostic point of view.

Recently, the RACE V trial investigators assessed the prevalence and characteristics of severe bradyarrhythmia and tachyarrhythmia episodes in patients with self-terminating paroxysmal AF.2 They found a higher than anticipated prevalence of bradyarrhythmias in patients with self-terminating paroxysmal AF. Sixty-nine out of 217 patients (nearly one-fifth) experienced ‘at least one episode of pauses ≥5 seconds or bradycardias ≤30 beats per minute’. Twenty-two patients with bradyarrhythmia episodes were part of the patients with concomitant tachyarrhythmias; 74% of bradyarrhythmia episodes were pauses ≥5 s; 47% of bradyarrhythmias occurred during the night, with exclusively nocturnal episodes observed in only 19% of patients with bradyarrhythmia. The …

View Full Text


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

  • © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Linked Articles